SUNNY GREEN: Open Payments
NPI 1649543752 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 28 payments from 10 companies in 2025. Trend: 2023 $618 · 2024 $575 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| Heron Therapeutics, Inc. | 2 | $233 |
| Abbott Laboratories | 9 | $151 |
| Astellas Pharma US Inc | 5 | $126 |
| Lilly USA, LLC | 1 | $120 |
| Daiichi Sankyo Inc. | 2 | $57 |
| ABBVIE INC. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Antares Pharma, Inc. | 2 | $41 |
| Boston Scientific Corporation | 1 | $26 |
| PFIZER INC. | 1 | $14 |
Products named: APONVIE, FREESTYLE LIBRE 3, Veozah, ZEPBOUND, INJECTAFER, REXULTI, XYOSTED, WATCHMAN FLX.
Industry payments across LA — which companies pay providers there.
